Oscar Health, Inc.
OSCR· NYSE· Hospital & Medical Service Plans
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- 3701.9%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- –
We record prices for the companies we cover; OSCR is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 262.4M
- Revenue
- $28.6M
- Free cash flow
- $1.1B
- Owner earnings
- $970.8M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -1386.2%
- Net
- -1549.9%
- Free cash flow
- 3701.9%
- Owner earnings
- 3395.3%
- Stock pay
- 306.6%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -45.3%
- ROE, 5 yr avg
- -37.2%
Growth (CAGR)
- Revenue, 3 yr
- -23.9%
- Revenue, 5 yr
- –
- Revenue, 6 yr
- -37.7%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 6 yr
- –
- Free cash flow, 3 yr
- 44.4%
- Free cash flow, 5 yr
- 38.4%
- Free cash flow, 6 yr
- –
Financial health · FY2025
- Cash and investments
- $4.0B
- Total debt
- $430.1M
- Net cash
- $3.6B
- Debt/Equity
- 0.4x
- Debt/FCF
- 0.4x
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 55.1%
Financials: ten years from the 10-Ks
Revenue
$28.6M
-37.7% a year over 6 years
FY2019FY2025
Margins
Operating-1386.2%Net-1549.9%
FY2025
FY2019FY2025
Free cash flow and owner earnings
Free cash flow$1.1BOwner earnings$970.8M
FY2025
FY2019FY2025
Diluted shares
262.4M
+810.7% over 6 years, net dilution
FY2019FY2025
Net cash
$3.6B
$3.6B more cash than debt
FY2019FY2025
Every figure, year by year
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| The business | |||||||
| Revenue | $488.2M | $0 | $5.4M | $64.9M | $21.4M | $20.6M | $28.6M |
| Revenue growth | – | -100.0% | – | 1103.7% | -67.1% | -3.6% | 39.0% |
| Gross margin | – | – | – | – | – | – | – |
| Operating margin | -53.1% | – | -10094.2% | -908.5% | -1103.4% | 278.3% | -1386.2% |
| Net income | -$261.2M | -$406.8M | -$572.6M | -$606.3M | -$270.7M | $25.4M | -$443.2M |
| Net margin | -53.5% | – | -10615.6% | -933.8% | -1267.9% | 123.6% | -1549.9% |
| Diluted EPS | $-9.06 | $-14.16 | $-3.20 | $-2.85 | $-1.22 | $0.10 | $-1.69 |
| Return on invested capital? | – | – | – | – | – | – | – |
| Cash | |||||||
| Operating cash flow | -$165.4M | $222.7M | -$181.7M | $380.3M | -$272.2M | $978.2M | $1.1B |
| Capital expenditure | $26.0M | $14.0M | $25.9M | $29.0M | $25.6M | $27.9M | $36.4M |
| Free cash flow | -$191.4M | $208.7M | -$207.6M | $351.3M | -$297.7M | $950.3M | $1.1B |
| Stock-based compensation | $33.6M | $35.9M | $86.3M | $112.3M | $159.7M | $109.8M | $87.7M |
| Owner earnings? | -$224.9M | $172.8M | -$293.9M | $239.0M | -$457.4M | $840.5M | $970.8M |
| Free cash flow per share | $-6.64 | $7.13 | $-1.16 | $1.65 | $-1.34 | $3.57 | $4.03 |
| Capital allocation | |||||||
| Dividends paid | – | – | – | – | – | – | – |
| Share repurchases | $3.0M | $0 | $0 | – | – | – | – |
| Diluted shares | 28.8M | 29.3M | 179.0M | 212.5M | 221.7M | 265.9M | 262.4M |
| Share count change? | – | 1.6% | 511.6% | 18.7% | 4.3% | 19.9% | -1.3% |
| Balance sheet | |||||||
| Cash and equivalents | $336.6M | $826.3M | $1.1B | $1.6B | $1.9B | $1.5B | $2.8B |
| Short-term investments | – | $366.4M | $587.1M | $1.4B | $689.8M | $624.5M | $1.2B |
| Total debt | – | $142.5M | $0 | $298.0M | $298.8M | $299.6M | $430.1M |
| Net debt | – | -$1.1B | -$1.7B | -$2.7B | -$2.3B | -$1.9B | -$3.6B |
| Shareholders' equity | $0 | -$1.3B | $1.4B | $890.4M | $804.0M | $1.0B | $977.6M |
Latest filings
| 2026-08-07 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Earnings release |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-05-06 | 8-K | Earnings release |
| 2026-04-22 | DEF 14A | Proxy statement |
| 2026-02-13 | 10-K | Annual report |
| 2026-02-10 | 8-K | Earnings release |
| 2025-11-06 | 10-Q | Quarterly report |
| 2025-11-06 | 8-K | Earnings release |
| 2025-08-07 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
